-
, Biochemistry, Cell Biology) or a related field (Chemistry, Chemical Engineering, Biomedical Engineering and Biological Engineering) with 3+ years or M.S with 1-2 years of relevant experience in either
-
stability. This position will closely collaborate with colleagues across PharmSci as well as with partners in Medicinal Chemistry, Pharmacokinetics & Drug Metabolism, and Clinical Pharmacology. You will be
-
expertise required for project progression. The individual will also work closely with the Medicinal Chemistry and Oncology Biology groups to innovate and develop the next-generation of therapies. ROLE
-
Keen to interact as a modeling and simulation expert with matrix project teams working closely with within PDM as well as biology, protein engineering, chemistry, safety and clinical scientists Strong
-
phase development and commercial Internal partners, including the other units in ORU, and partner lines such as Medicinal Chemistry, Biomedicine Design and Drug Safety External collaborators including
-
technical expertise required for project progression. The individual will also work closely with the Medicinal Chemistry and Oncology Biology groups to innovate and develop the next-generation of therapies
-
) Familiarity with version control and collaborative programming (e.g., Git) Strong scientific background, with good working knowledge of biology, chemistry, pharmacology, or toxicology. NON-STANDARD WORK
-
, JMP, and GraphPad Prism) Familiarity with version control and collaborative programming (e.g., Git) Strong scientific background, with good working knowledge of biology, chemistry, pharmacology
-
collaborations, presenting at conferences, and contributing publications. QUALIFICATIONS Must-Have Ph.D. in Biological Sciences, Proteomics, Chemical Biology, Analytical Chemistry, or a related field 6+ years
-
development and team leadership for Pfizer Oncology's Scientific Affairs team. QUALIFICATIONS Key requirements PhD in Biology, Chemistry, or other scientific discipline, or equivalent required 10+ years